NUVB

$4.16-0.72%

Nuvation Bio Inc.

Market Cap

$1.5B

Live price × SEC shares (Oct 30, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.70

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

7.3

TTM to Sep 2026 · revenue

P/B

6.4

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Sep 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	41,865	83,228	31,687	44,951	201,731
Research & development	34,297	35,047	30,661	32,679	132,684
Selling, general & administrative	40,326	38,309	42,591	42,553	163,779
Total operating expenses	75,902	79,347	82,723	87,161	325,133
Operating income	(34,037)	3,881	(51,036)	(42,210)	(123,402)
Interest expense	5,017	6,708	6,759	881	19,365
Pretax income	(36,592)	5,397	(62,840)	(41,899)	(135,934)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(36,592)	5,397	(62,840)	(41,899)	(135,934)
EPS (basic) ($)		0.02	(0.18)	(0.12)	(0.39)
EPS (diluted) ($)		0.01	(0.18)	(0.12)	(0.39)
Weighted avg. shares (basic)		347,332	348,770	351,861
Weighted avg. shares (diluted)		—	348,770	351,861

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 4, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 23 more quarters, back to Mar 2020, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 4, 2026 accepted 4:18 PM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

39%

W/W -32.1pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

1.25x

Avg Daily Selling (90d)

1,111 sh/day

Baseline Daily Selling

2,132 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-19	2026-08-21	Hattersley Gary	CHIEF SCIENTIFIC OFFICER	Sale	100.0K	$7.09	$709K	0	View
2026-06-23	2026-06-24	Markel Stacy	CHIEF PEOPLE OFFICER	Sale	125.0K	$6.03	$753K	32.6K	View
2026-06-23	2026-06-24	Wentworth Kerry	CHIEF REGULATORY OFFICER	Sale	63.0K	$6.02	$379K	53.0K	View
2026-06-23	2026-06-24	Sauvage Philippe	Chief Financial Officer	Sale	47.7K	$6.01	$286K	12.7K	View
2026-06-09	2026-06-11	Mashal Robert	Director	Purchase	25.0K	$4.73	$118K	225.0K	View

1–5 of 8

1 / 2

Recent News

Nuvation Bio stock hits 52-week low at 4.04 USD By Investing.com

Investing.com India · 2026-11-06

Nuvation Bio Stock In Focus After Earnings And Phase 3 Trial Expansion

Simply Wall St · 2026-11-06

Nuvation Bio Inc. (NUVB) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-05

Nuvation Bio (NUVB) Q3 2026 Earnings Call Transcript

Yahoo Finance · 2026-11-05

Nuvation Bio Inc (NUVB) Q3 2026 Earnings Call Highlights: IBTROZI Revenue Climbs 18% as ...

Yahoo Finance · 2026-11-05

Nuvation Bio Q3 2026 Earnings Call Transcript

Benzinga · 2026-11-04

Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Beats Revenue Estimates

Yahoo Finance · 2026-11-04

Quarterly revenue rose from $13.1M at Nuvation Bio (NUVB), while its net loss narrowed.

Stock Titan · 2026-11-04

Top 3 Penny Stocks To Watch In November 2026

Yahoo Finance · 2026-11-03

Nuvation Bio to Present Additional Updated Phase 2 Results at 2026 Society for Neuro-Oncology Annual Meeting

Yahoo Finance · 2026-11-02

Nuvation Bio to Expand Pivotal Phase 3 SIGMA Study of Safusidenib for IDH1-Mutant Glioma to Six European Countries

Yahoo Finance · 2026-10-29

Nuvation Bio And 2 More Penny Stocks To Watch

Yahoo Finance · 2026-10-24

Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026

Yahoo Finance · 2026-10-21

Nuvation, Jazz gain new Buys at Citi on oncology prospects

Seeking Alpha · 2026-09-30

Nuvation Bio Q2 Earnings Call Highlights

Yahoo Finance · 2026-08-08

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-08-19	Hattersley Gary	S	100,000	$709,240
2026-06-23	Markel Stacy	S	125,000	$753,187.5
2026-06-23	Wentworth Kerry	S	63,000	$379,190.7
2026-06-23	Sauvage Philippe	S	47,668	$286,370.28
2026-06-09	Mashal Robert	P	25,000	$118,250

NUVB

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Nuvation Bio Inc. (NUVB)

Reporting Insiders

Factor Profile

Corporate Events (8-K)